Carson Wealth (CWM LLC)
CDTX

Carson Wealth (CWM LLC)’s Cidara Therapeutics CDTX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-474
Closed -$105K – 5697
2025
Q4 		$105K Buy
474
+469
+9,380% +$75.8K ﹤0.01% 3018
2025
Q3 		$0 Buy
+5
New +$319 ﹤0.01% 5295

Carson Wealth (CWM LLC)'s CDTX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 474 shares — an estimated $105K sold.

Carson Wealth (CWM LLC) first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $105K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • Carson Wealth (CWM LLC) reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 474 Cidara Therapeutics shares in Q1 2026, an estimated $105K.
  • Carson Wealth (CWM LLC) first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
  • Carson Wealth (CWM LLC)'s Cidara Therapeutics position peaked at $105K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.